July 8, 2020
PAR-18-657 - Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 Clinical Trial Optional)
NOT-NS-18-072 - Rescinded - Notice of New Budget Limitation for PAR-18-657 Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 Clinical Trial Optional)
National Institute of Neurological Disorders and Stroke (NINDS)
National Eye Institute (NEI)
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
National Institute on Drug Abuse (NIDA)
National Institute of Environmental Health Sciences (NIEHS)
The purpose of this notice is to inform applicants of a change to the Application Budgets for PAR-18-657 "Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 Clinical Trial Optional)". This notice updates, supercedes and replaces the previous notice, NOT-NS-18-072 "Notice of New Budget Limitation for PAR-18-657 Countermeasures Against Chemical Threats (CounterACT) Research Centers of Excellence (U54 Clinical Trial Optional)". Specifically, the application budgets will be reduced from $2 million in direct costs per yearto $1.75 million in direct costs per year. This notice will be effective for the October 8, 2020 receipt date. Change is shown below in bold italics.
Currently Reads:
Section II. Award Information
Award Budget |
Application budgets may not exceed $2.0 million in direct costs per year. Many applications will not need to request the maximum budget and the size and duration of the awards will vary because the nature and scope of research programs will vary. |
Modified to Read:
Section II. Award Information
Award Budget |
Application budgets may not exceed $1.75 million in direct costs per year. Many applications will not need to request the maximum budget and the size and duration of the awards will vary because the nature and scope of research programs will vary. |
All other aspects of this FOA remain unchanged.
David A. Jett, Ph.D.
National Institute of Neurological Disorder and Stroke (NINDS)
Telephone: 301-496-6035
Email:[email protected]